Researchers are studying the activity of PCSK9, which is potentiated through HDL binding. The role of PCSK9 is being explored beyond its effects on cholesterol, including its potential impact on immunotherapy and possible sex differences in its circulation. Further research is being conducted to understand the contributions and implications of PCSK9.